Cargando…
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
BACKGROUND: Environmental impact assessments of pharmaceuticals typically consider only a part of the pharmaceutical supply chain, e.g. tablet formulation. While the environmental impact can be expressed in environmental Human Health burden due to resource use and emissions, the Human Health benefit...
Autores principales: | Debaveye, Sam, De Smedt, Delphine, Heirman, Bert, Kavanagh, Shane, Dewulf, Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585029/ https://www.ncbi.nlm.nih.gov/pubmed/31217000 http://dx.doi.org/10.1186/s12913-019-4247-2 |
Ejemplares similares
-
The public health benefit and burden of mass drug administration programs in Vietnamese schoolchildren: Impact of mebendazole
por: Debaveye, Sam, et al.
Publicado: (2018) -
Correction: Quantifying the handprint—Footprint balance into a single score: The example of pharmaceuticals
por: Debaveye, Sam, et al.
Publicado: (2020) -
Quantifying the handprint—Footprint balance into a single score: The example of pharmaceuticals
por: Debaveye, Sam, et al.
Publicado: (2020) -
PM394. The outcome of paliperidone palmitate in schizophrenia
por: Ju, Po-Chung
Publicado: (2016) -
Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan
por: Mahlich, Jörg, et al.
Publicado: (2015)